Clinical Trials Logo

Clinical Trial Summary

Prospective cohort study on the long-term effectiveness and safety of PINS vagus nerve stimulators for children and adolescent with refractory epilepsy.


Clinical Trial Description

Epileptic encephalopathy is very common in children and adolescent with epilepsy, but there is no data in clinical studies.The aim of this study is to evaluate the efficacy of the long-term vagus nerve stimulation for children and adolescent with epilepsy ;


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT02603991
Study type Observational
Source Beijing Pins Medical Co., Ltd
Contact Fumin Jia, PhD
Phone +86-010-59361265
Status Recruiting
Phase N/A
Start date June 2016
Completion date October 2017

See also
  Status Clinical Trial Phase
Recruiting NCT01858285 - Genetics of Epilepsy and Related Disorders
Recruiting NCT04802135 - Creation of a Register of Patients With Neonatal-onset Epileptic Encephalopathy
Terminated NCT03955432 - Long-term Cardiac Monitoring in Epilepsy N/A
Recruiting NCT05722990 - Genetic Investigations in Children With Developmental and Epileptic Encephalopathies in Ho Chi Minh City, Vietnam
Enrolling by invitation NCT05301894 - Extension Study to Evaluate NBI-827104 in Pediatric Participants With Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep Phase 2
Recruiting NCT04496310 - Tele-epic (Telemedicine for Epilepsy Care) N/A
Recruiting NCT03934268 - A Cohort Study on the Prognosis of Neonatal KCNQ2 Gene-associated Epileptic Encephalopathy
Completed NCT04625101 - Efficacy, Safety, Tolerability, and Pharmacokinetics of NBI-827104 in Pediatric Subjects With Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep Phase 2
Active, not recruiting NCT03024827 - Cannabidiol in Children With Refractory Epileptic Encephalopathy Phase 1
Active, not recruiting NCT03936777 - A Study to Investigate the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution in Children and Adults With Epileptic Encephalopathy Including Dravet Syndrome and Lennox-Gastaut Syndrome Phase 3